{"id":43834,"date":"2019-01-07T17:23:29","date_gmt":"2019-01-07T16:23:29","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=43834"},"modified":"2019-01-21T12:46:42","modified_gmt":"2019-01-21T11:46:42","slug":"ann-robinsons-research-reviews-7-january-2019","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/","title":{"rendered":"Ann Robinson&#8217;s research reviews\u20147 January 2019"},"content":{"rendered":"<p class=\"standfirst\">Ann Robinson reviews the latest research from the top medical journals<\/p>\n<p><!--more--><\/p>\n<p><strong><a href=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-42949\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg\" alt=\"\" width=\"160\" height=\"160\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg 160w, https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2-150x150.jpg 150w\" sizes=\"auto, (max-width: 160px) 100vw, 160px\" \/><\/a><b>NEJM<\/b><\/strong><\/p>\n<p><b>Ibrutinib for untreated chronic lymphocytic leukaemia<\/b><\/p>\n<p><span style=\"font-weight: 400\">Ibrutinib, <\/span><span style=\"font-weight: 400\">a B cell receptor inhibitor,<\/span><span style=\"font-weight: 400\"> has been approved for the treatment of untreated chronic lymphocytic leukaemia since 2016. <\/span><span style=\"font-weight: 400\">\u00a0But it hasn\u2019t been compared with other chemoimmunotherapy options until this <\/span><span style=\"font-weight: 400\"><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1812836?query=featured_home\">phase 3 trial of patients aged 65 years<\/a> or older with untreated chronic lymphocytic leukaemia. The conclusion is that ibrutinib gives longer progression-free survival (87% at 2 years) than bendamustine plus rituximab (74%), and that ibrutinib on its own is as good as ibrutinib plus rituximab.<\/span><\/p>\n<p><b>Fixing secondary mitral regurgitation<\/b><\/p>\n<p><span style=\"font-weight: 400\">Mitral regurgitation is often secondary to a diseased left ventricle rather than a primary problem with the mitral valve itself. Early surgery for severe primary mitral regurgitation is accepted practice, but it\u2019s unclear what to do in secondary mitral regurgitation. Two new studies come to different conclusions. <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1805374\">One found that percutaneous mitral valve repair<\/a> with medical therapy was no better than medical therapy alone in preventing death or hospital admission with heart failure at 1 year. <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1806640\">A second study<\/a> found the opposite. Transcatheter mitral valve repair resulted in a lower rate of hospitalisation for heart failure and lower all cause mortality within 24 months of follow-up than medical therapy alone.<\/span><\/p>\n<p><strong>Lancet<\/strong><\/p>\n<p><b>Drink-driving\u2014no easy solutions<\/b><\/p>\n<p><span style=\"font-weight: 400\">Fatal road traffic incidents in the UK have fallen substantially (72% reduction from 1979-2017), but alcohol remains a major risk factor for deaths related to driving. Scotland lowered the legal blood alcohol concentration limit for drivers from 0.08 g\/dL to 0\u00b705 g\/dL in 2014. <a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(18)32850-2\/fulltext\">This study looked at data<\/a> on road traffic incidents and alcohol consumption in Scotland and in England and Wales\u2014where the limit has not been lowered. It didn\u2019t find any reduction in road traffic incidents, but there was a small fall in alcohol sales. Just lowering the legal blood alcohol concentration limit may not be enough to prevent deaths. Other public health measures, such as better legal enforcement and social attitudinal shifts, may help.<\/span><\/p>\n<p><b>JAMA Intern Med<\/b><\/p>\n<p><b>Encouraging exercise for older people<\/b><\/p>\n<p><span style=\"font-weight: 400\">Exhorting older people to exercise has become standard advice for a wide range of conditions, but do we have evidence to support this? <a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2719424\">This meta-analysis of 40 long term randomised clinical trials<\/a> including 21,<\/span><span style=\"font-weight: 400\">868 participants found that long term exercise (a year or more), particularly moderate intensity multicomponent training with balance exercises, performed 2 to 3 times per week, appears to be safe and effective and reduces the risk of falling in older people. The effect is modest; to prevent one older person from falling or being injured in a fall, 20 and 27 individuals, respectively, would need to participate in a long term exercise intervention and 100 would need to take part to prevent a fracture. There was no overall reduction in mortality and exercise did not reduce the risk of multiple falls and hospitalisation.<\/span><\/p>\n<p><b>Targeted electronic health record alerts <\/b><\/p>\n<p><span style=\"font-weight: 400\">Cardiac monitoring, or telemetry, can provide early detection of sudden cardiac death, arrhythmias, and ECG changes, but can be used unnecessarily or for too long. \u201cAlarm fatigue\u201d<\/span><span style=\"font-weight: 400\">\u2014<\/span><span style=\"font-weight: 400\">desensitization to alarms when they are frequently false or irrelevant<\/span><span style=\"font-weight: 400\">\u2014<\/span><span style=\"font-weight: 400\">can set in so that potentially important signals are ignored. <a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2717954\">In this cluster-randomized clinical trial of 1066 hospitalisations<\/a>, teams on a general medicine service received an electronic health record (EHR) alert when a patient\u2019s telemetry had run its pre-set duration. \u201cIn response to the alert, physicians chose to discontinue monitoring 62% of the time, resulting in a reduction of monitoring duration per hospitalisation with no increase in potential adverse events\u2019\u201d say the authors. A targeted EHR alert appears to safely reduce unnecessary cardiac monitoring without the need for human beings to check on the devices. No mention is made of the potential benefit of checking on the patient.<\/span><\/p>\n<p><strong>JAMA<\/strong><\/p>\n<p><b>Pain caused by knee osteoarthritis: what helps?<\/b><\/p>\n<p><span style=\"font-weight: 400\">Older people come into GP surgeries with pain caused by knee osteoarthritis and GPs have so little to offer. So, I welcome this <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2719308\">systematic review and meta-analysis<\/a> of 33 pharmacological interventions which included 22<\/span><span style=\"font-weight: 400\">\u2009<\/span><span style=\"font-weight: 400\">037 patients with knee osteoarthritis in 47 randomised clinical trials lasting at least 12 months. Unfortunately, the conclusion is that nothing works convincingly. The authors say: \u201cthere was uncertainty around the estimates of effect size for change in pain for all comparisons with placebo, including the two medications that were associated with improved pain (celecoxib and glucosamine sulfate).\u201d <\/span><\/p>\n<p><b>Bring me sunshine; but vitamin D is no panacea<\/b><\/p>\n<p><span style=\"font-weight: 400\">Vitamin D is not the panacea it was heralded to be despite its important roles in calcium metabolism and the immune system. <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2718066\">This study asked whether treatment<\/a> with active vitamin D reduces cardiovascular risk in patients undergoing haemodialysis; the rationale being that patients with renal failure have an increased susceptibility to heart disease. An open-label randomized clinical trial of 976 patients on maintenance dialysis without secondary hyperparathyroidism, found that adding oral alfacalcidol (the active component of vitamin D) over a median of 4 years did not reduce cardiovascular events, which occurred in 21.1% of \u00a0patients.<\/span><\/p>\n<p><b>Annals of Internal Medicine<\/b><\/p>\n<p><b>Childbirth increases the risk of breast cancer<\/b><\/p>\n<p><span style=\"font-weight: 400\">I was taught that women who had never been pregnant were at increased risk of breast cancer<\/span><span style=\"font-weight: 400\">\u2014<\/span><span style=\"font-weight: 400\">the implication was that the more menstrual cycles you have, the greater your exposure to oestrogen, and the higher the risk. But although pregnancy, with its break from periods, may be protective, there appears to be an increase in diagnosis of breast cancer shortly after giving birth. <a href=\"http:\/\/annals.org\/aim\/article-abstract\/2718682\/breast-cancer-risk-after-recent-childbirth-pooled-analysis-15-prospective\">Pooled data from 15 prospective cohort studies of women under 55 found just over 18,000 diagnoses of breast cancer in 9.6 million person-years of follow-up<\/a>. Compared with nulliparous women, parous women had an increased risk of estrogen receptor positive breast cancer which peaked around five years after birth; the risk was greater in women with a family history of breast cancer, those who were older at first birth or who went on to give birth again. Breastfeeding made no difference. As time went on (24 years after childbirth), the risk of breast cancer in nulliparous women overtook the risk in parous women. The authors say \u201ccompared with nulliparous women, parous women have an increased risk for breast cancer for more than 20 years after childbirth. Healthcare providers should consider recent childbirth a risk factor for breast cancer in young women.\u201d<\/span><\/p>\n<p><b>Diabetes drug canagliflozin doesn\u2019t increase fractures<\/b><\/p>\n<p><span style=\"font-weight: 400\">Canagliflozin is used in the treatment of diabetes. It has been approved by the National Institute for Health and Care Excellence as monotherapy if metformin is inappropriate, or as an add on to insulin or other diabetes drugs. But canagliflozin can affect calcium, phosphate, and vitamin D homeostasis and is associated with decreased bone mineral density. The question is whether taking the drug increases the risk of fractures? \u00a0<a href=\"http:\/\/annals.org\/aim\/article-abstract\/2719985\/fracture-risk-after-initiation-use-canagliflozin-cohort-study\">This cohort study of nearly 80,000 people<\/a> has reassuring news. In middle aged patients with type 2 diabetes and relatively low risk of fracture (just over 2\/1000 person years), canagliflozin was not associated with an increased risk of fractures compared with GLP-1 agonists.<\/span><\/p>\n<p><b>BMJ<\/b><\/p>\n<p><b>Artificial sweeteners and health<\/b><\/p>\n<p><a href=\"https:\/\/www.bmj.com\/content\/364\/bmj.k4718\">This systematic review of 56 studies of adults and children found that use of non-sugar sweeteners (NSS)<\/a> made little or no difference to a wide range of health outcomes. \u201cNo evidence was seen for health benefits from NSSs and potential harms could not be excluded,\u201d say the authors. The main outcomes were body weight or body mass index, glycaemic control, cardiovascular and kidney disease, cancer, oral health, preference for a sweet taste, eating behaviour, mood, behaviour, neurocognition and adverse effects. Most people use NSSs to cut down calories and exposure to sugar which could lead to obesity and diabetes. But there\u2019s an argument that NSSs encourage a \u201csweet tooth\u201d and do nothing to encourage healthy eating, which offsets the benefits. In the 17 randomised controlled trials studied, adults given NSSs didn\u2019t lose significantly more weight than those given different sugars or placebo. The authors admit that \u00a0\u201cthe certainty of the included evidence ranged from very low to moderate, and our confidence in the reported effect estimates is accordingly limited.\u201d<\/p>\n<p><em><strong>Ann Robinson<\/strong>\u00a0is an NHS GP and health writer\/broadcaster. She works within her local community and is a trustee of the Anthony Nolan charity.<\/em><\/p>\n<p><em><strong>Competing interests<\/strong>: None declared.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ann Robinson reviews the latest research from the top medical journals [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18902],"tags":[],"class_list":["post-43834","post","type-post","status-publish","format-standard","hentry","category-weekly-research-reviews"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ann Robinson&#039;s research reviews\u20147 January 2019 - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ann Robinson&#039;s research reviews\u20147 January 2019 - The BMJ\" \/>\n<meta property=\"og:description\" content=\"Ann Robinson reviews the latest research from the top medical journals [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-07T16:23:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-21T11:46:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Ann Robinson&#8217;s research reviews\u20147 January 2019\",\"datePublished\":\"2019-01-07T16:23:29+00:00\",\"dateModified\":\"2019-01-21T11:46:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/\"},\"wordCount\":1339,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/ann_robinson2.jpg\",\"articleSection\":[\"Weekly review of medical journals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/\",\"name\":\"Ann Robinson's research reviews\u20147 January 2019 - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/ann_robinson2.jpg\",\"datePublished\":\"2019-01-07T16:23:29+00:00\",\"dateModified\":\"2019-01-21T11:46:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/ann_robinson2.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/ann_robinson2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/01\\\/07\\\/ann-robinsons-research-reviews-7-january-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ann Robinson&#8217;s research reviews\u20147 January 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ann Robinson's research reviews\u20147 January 2019 - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/","og_locale":"en_US","og_type":"article","og_title":"Ann Robinson's research reviews\u20147 January 2019 - The BMJ","og_description":"Ann Robinson reviews the latest research from the top medical journals [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2019-01-07T16:23:29+00:00","article_modified_time":"2019-01-21T11:46:42+00:00","og_image":[{"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg","type":"","width":"","height":""}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Ann Robinson&#8217;s research reviews\u20147 January 2019","datePublished":"2019-01-07T16:23:29+00:00","dateModified":"2019-01-21T11:46:42+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/"},"wordCount":1339,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg","articleSection":["Weekly review of medical journals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/","url":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/","name":"Ann Robinson's research reviews\u20147 January 2019 - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg","datePublished":"2019-01-07T16:23:29+00:00","dateModified":"2019-01-21T11:46:42+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/ann_robinson2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/01\/07\/ann-robinsons-research-reviews-7-january-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Ann Robinson&#8217;s research reviews\u20147 January 2019"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/43834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=43834"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/43834\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=43834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=43834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=43834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}